Peer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?

Prediction market on manifold. Particularly against severe / pandemic-risk disease such as CoV-2, H5N1, or so on. Resolves YES if one is published which shows statistically significant effects using mushroom or mycelium-derived extracts or compounds. Otherwise NO at end of 2026.

Liquidity: $1,000. Resolves: 12/31/2026.